Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Sonic Healthcare Limited ( (AU:SHL) ) is now available.
Sonic Healthcare Limited announced a change in the director’s interest, with Director Katharine Giles acquiring an additional 1,000 fully paid ordinary shares, bringing her total to 5,600 shares. This on-market purchase reflects a continued investment in the company, potentially indicating confidence in Sonic Healthcare’s future performance and stability, which may reassure stakeholders and investors.
The most recent analyst rating on (AU:SHL) stock is a Hold with a A$23.80 price target. To see the full list of analyst forecasts on Sonic Healthcare Limited stock, see the AU:SHL Stock Forecast page.
More about Sonic Healthcare Limited
Sonic Healthcare Limited operates in the healthcare industry, primarily focusing on providing medical diagnostic services. The company is known for its comprehensive range of laboratory and radiology services, catering to various healthcare needs across multiple markets.
Average Trading Volume: 1,528,027
Technical Sentiment Signal: Sell
Current Market Cap: A$10.4B
See more insights into SHL stock on TipRanks’ Stock Analysis page.